Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Creative Biosciences (Guangzhou) Co., Ltd.
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
Advaxis, Inc.
Advaxis, Inc.
Umeå University
H. Lee Moffitt Cancer Center and Research Institute
Revolution Medicines, Inc.
Fate Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
MacroGenics
Takeda
Mayo Clinic
Celgene
Lumos Pharma
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center
Tianjin Medical University Cancer Institute and Hospital
Celgene
Mayo Clinic
Sanofi
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Infinity Pharmaceuticals, Inc.
Axelar AB
Siemens Molecular Imaging
Pharmacyclics LLC.
Eli Lilly and Company